Alveolar proteinosis

European Respiratory Monograph

Volumn 5, Issue 14, 2000, Pages 194-205

  Costabel, U ^a   Guzman, J ^a  

^a RUHRLANDKLINIK   (Germany)

Author keywords

Alveolar proteinosis; Surfactant protein; Whole lung lavage

Indexed keywords

SURFACTANT ASSOCIATED PROTEIN;

CLINICAL FEATURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG LAVAGE; LUNG TRANSPLANTATION; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; THORAX RADIOGRAPHY;

EID: 0033817095     PISSN: 1025448X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Pulmonary alveolar proteinosis
2. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis)
3. Diagnosing pulmonary alveolar proteinosis
4. Pulmonary alveolar proteinosis and nocardiosis
5. Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy
6. Association of pulmonary alveolar lipoproteinosis with mycobacterial infection
7. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis
8. Pulmonary alveolar proteinosis associated with Pneumocystis carinii
9. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome
10. Are AIDS patients at risk for pulmonary alveolar proteinosis?
11. Acute silico-proteinosis: A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis
12. Pulmonary alveolar proteinosis and aluminum dust exposure
13. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium
14. Acute silicolipoproteinosis
15. Pulmonary alveolar proteinosis with hematologic disorders
16. Pulmonary alveolar proteinosis: Its association with hematologic malignancy and lymphoma
17. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients
18. Pulmonary alveolar proteinosis: Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it
19. Pulmonary alveolar proteinosis: Clinical features and outcomes
20. Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis
21. Childhood pulmonary alveolar proteinosis
22. Pulmonary alveolar proteinosis in two siblings with decreased immunoglobulin A
23. Pulmonary alveolar proteinosis
24. Pulmonary alveolar proteinosis; experience with eight pediatric cases and a review
25. Pulmonary alveolar proteinosis in four siblings
26. Bronchoalveolar lavage cell data in alveolar proteinosis
27. Alveolar proteinosis: Diagnosis and treatment over a 10-year period
28. Metabolic and other diseases
29. Diagnosis and management of alveolar proteinosis: The role of electron microscopy
30. Classification and morphometric quantitation of insoluble materials from the lungs of patients with alveolar proteinosis
31. Pulmonary alveolar proteinosis
32. Lipoprotein macroaggregates in BAL fluid from patients with diffuse interstitial lung diseases: Comparison with idiopathic alveolar proteinosis
33. Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis
34. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis
35. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis
36. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis
37. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids
38. Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells
39. Pulmonary surfactant in health and human lung diseases: State of the art
40. Pathogenesis of experimental pulmonary alveolar proteinosis
41. Pulmonary reaction to metallic aluminium powders: An experimental study
42. Pulmonary response to glass fiber by inhalation exposure
43. Changes in the composition of lung lipids and the 'turnover' of dipalmitoyi lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz
44. Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis
45. Defective lung macrophages in pulmonary alveolar proteinosis
46. Macrophage function in pulmonary alveolar proteinosis
47. Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages
48. Granulocyte/macrophage colony-stimulating factor-deficient mice show no perturbation of hematopoiesis but develop a characteristic pulmonary pathology
49. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
50. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF deficient mice
51. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukin 3/5 βc receptor-deficient mice is reversed by bone marrow transplantation
52. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice
53. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression
54. Human alveolar proteinosis associated with GM-CSF cDNA mutation
55. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis
56. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor
57. Granulocyte-macrophage colony stimulating factor (GM-CSF) and alveolar proteinosis
58. GM-CSF in alveolar macrophages in pulmonary alveolar proteinosis
59. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis
60. Treatment of pulmonary alveolar proteinosis (PAP): Is GM-CSF an option?
61. Therapy of idiopathic acquired alveolar proteinosis with granulocyte-macrophage colony-stimulating factor (GM-CSF)
62. Prospective trial of granulocyte macrophage-colony stimulating fator (GM-CSF) in the treatment of pulmonary alveolar proteinosis (PAP)
63. Pulmonary alveolar phospholipoproteinosis: Experience with 34 cases and a review
64. Pulmonary alveolar proteinosis. A roentgenologic analysis
65. Pulmonary alveolar proteinosis: CT findings
66. Computed tomography appearances of pulmonary alveolar proteinosis
67. Pulmonary alveolar proteinosis: High-resolution CT, chest radiographic, and functional correlations
68. Pulmonary alveolar proteinosis. Shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis
69. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis
70. Serum and lavage lactate dehydrogenase isoenzymes in pulmonary alveolar proteinosis
71. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis
72. Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis
73. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis
74. The clinical role of BAL in rare pulmonary diseases
75. Pulmonary alveolar proteinosis: The diagnosis by segmental lavage
76. Bronchopulmonary lavage in man
77. The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: A ten-year experience
78. Pulmonary-alveolar proteinosis: Prospective clinical experience in 23 patients for 15 years
79. Role of bronchoalveolar lavage in the treatment of respiratory failure
80. Pulmonary interstitial fibrosis following alveolar proteinosis
81. Case report: Interstitial fibrosis after uncomplicated pulmonary alveolar proteinosis
82. Pulmonary alveolar proteinosis with interstitial involmement
83. Recurrent alveolar proteinosis following double lung transplantation